Products found to contain undeclared medicines
|
| |
| Australia : Ja Dera Max+ capsules pose serious health risks containing undeclared substance lignocaine |
| |
The Therapeutic Goods Administration (TGA) has tested a product labelled Ja Dera Max+ capsules and found that the capsules contained the undeclared substance lignocaine (also known as lidocaine) which is widely used as an anaesthetic and antiarrhythmic drug.
Ja Dera Max+ capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
TGA investigations have shown that a number of people in Australia may have bought the product online.
There is a similar counterfeit product Ja Dera 100% Weight Loss Supplement capsules which also contains other undeclared pharmaceuticals such as sibutramine. Sibutramine was withdrawn from world markets in 2010 due to increased risk of cardiac events and stroke.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/ja-dera-max-capsules
In Hong Kong, the above products are not registered pharmaceutical products. Related news was issued by United States Food and Drug Administration (US FDA) and TGA, and was posted on the Drug Office website on 20th October 2011 and 3rd June 2015.
Ends/ Thursday, March 8, 2018
Issued at HKT 14:30
|
| |
|
